Literature DB >> 33392346

18F-THK 5351 and 11C-PiB PET of the Thai normal brain template.

Chanisa Chotipanich1, Supaporn Kongthai1, Anchisa Kunawudhi1, Chetsadaporn Promteangtrong1, Attapon Jantarato1.   

Abstract

OBJECTIVES: The aim of the study was to create a local normal database brain template of Thai individuals for 11C-Pittsburgh compound B (11C-PiB) and 18F-THK 5351 depositions using statistical parametric mapping (SPM) software, and to validate and optimize the established specific brain template for use in clinical practice with a highly reliability and reproducibility.
METHODS: This prospective study was conducted in 24 healthy right-handed volunteers (13 men, 11 women; aged: 42-79 years) who underwent 18F-THK 5351 and 11C-PiB PET/CT scans. SPM was used for the 18F-THK 5351 and 11C-PiB PET/CT image analysis. All PET images were processed individually using Diffusion Tensor Image -Magnetic Resonance Imaging-weighted images (DTI-MRI images), which involved: (1) conversion of Digital Imaging and Communications in Medicine (DICOM) files into an analyzable file extension (.NIFTI) for statistical parametric mapping, (2) setting of the origin (the anterior commissure was used as the anatomical landmark), (3) re-alignment, (4) co-registration of PET with B0 (T1W) and DTI-MRI images, (5) normalization, and (6) normal verification using the Thai MRI standard. We then compared the normal PET template with the abnormal deposition area of different dementia syndromes, including Alzheimer's disease and progressive supranuclear palsy.
RESULTS: This method was able to differentiate cognitively normal from Alzheimer's disease and progressive supranuclear palsy subjects.
CONCLUSIONS: This normal brain template was able to be integrated into clinical practice and research using PET analyses at our center.
© 2021 mums.ac.ir All rights reserved.

Entities:  

Keywords:  Amyloid; Brain template; Tau protein

Year:  2021        PMID: 33392346      PMCID: PMC7701232          DOI: 10.22038/AOJNMB.2020.49623.1338

Source DB:  PubMed          Journal:  Asia Ocean J Nucl Med Biol        ISSN: 2322-5718


  24 in total

Review 1.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

Review 2.  Tau PET imaging in Alzheimer's disease.

Authors:  Nobuyuki Okamura; Ryuichi Harada; Shozo Furumoto; Hiroyuki Arai; Kazuhiko Yanai; Yukitsuka Kudo
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

Review 3.  PET imaging of brain amyloid in dementia: a review.

Authors:  Harriet Quigley; Sean J Colloby; John T O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-28       Impact factor: 3.485

Review 4.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 5.  Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Alex Ward; Sheila Crean; Catherine J Mercaldi; Jenna M Collins; Dylan Boyd; Michael N Cook; H Michael Arrighi
Journal:  Neuroepidemiology       Date:  2011-12-17       Impact factor: 3.282

6.  Construction of a novel Chinese normal brain database using 18F-FDG PET images and MIMneuro software, the initial application in epilepsy.

Authors:  Longxiao Wei; Kun Guo; Yunbo Li; Zhirui Guo; Chengcheng Gao; Menghui Yuan; Ming Zhang
Journal:  Int J Neurosci       Date:  2018-12-20       Impact factor: 2.292

7.  Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.

Authors:  Kok Pin Ng; Tharick A Pascoal; Sulantha Mathotaarachchi; Joseph Therriault; Min Su Kang; Monica Shin; Marie-Christine Guiot; Qi Guo; Ryuichi Harada; Robert A Comley; Gassan Massarweh; Jean-Paul Soucy; Nobuyuki Okamura; Serge Gauthier; Pedro Rosa-Neto
Journal:  Alzheimers Res Ther       Date:  2017-03-31       Impact factor: 6.982

8.  Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity.

Authors:  R Duara; D A Loewenstein; G Lizarraga; M Adjouadi; W W Barker; M T Greig-Custo; M Rosselli; A Penate; Y F Shea; R Behar; A Ollarves; C Robayo; K Hanson; M Marsiske; S Burke; N Ertekin-Taner; D Vaillancourt; S De Santi; T Golde; DeKosky St
Journal:  Neuroimage Clin       Date:  2019-03-27       Impact factor: 4.881

Review 9.  Biomarkers for tau pathology.

Authors:  Michael Schöll; Anne Maass; Niklas Mattsson; Nicholas J Ashton; Kaj Blennow; Henrik Zetterberg; William Jagust
Journal:  Mol Cell Neurosci       Date:  2018-12-07       Impact factor: 4.314

Review 10.  The development and validation of tau PET tracers: current status and future directions.

Authors:  Nobuyuki Okamura; Ryuichi Harada; Aiko Ishiki; Akio Kikuchi; Tadaho Nakamura; Yukitsuka Kudo
Journal:  Clin Transl Imaging       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.